EUVIMEDEUVIMED entdecken
Open Access

Office‐Based Blue Laser Therapy and Steroid Injection of Hemorrhagic and Nonhemorrhagic Vocal Fold Polyp

Abdul-Latif Hamdan iD, Patrick Abou Raji Feghali, Lana Ghzayel, Ghena Lababidi, Valerie Sarkis, Jad Hosri iD, Elie Alam, Marc Mourad

The Laryngoscope · 2026

DOI: 10.1002/lary.70671 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, 2026. Verfasst von Abdul-Latif Hamdan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head and Neck Surgery, American University of Beirut Medical Center, Beirut, Lebanon. Hauptthemen laut MEDLINE: Polyps, Vocal Cords, Laryngeal Diseases, Hemorrhage. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the correlation between the morphology of vocal fold polyps, hemorrhagic versus nonhemorrhagic, and treatment outcome following office‐based blue laser therapy with intralesional steroid injection.

Methods

All the medical records and video recordings of patients diagnosed with vocal fold polyps who underwent office‐based blue laser therapy with intralesional steroid injection at a tertiary referral center between June 2023 and August 2025 were reviewed. Vocal fold polyps were classified as hemorrhagic versus nonhemorrhagic. The treatment outcome measures included the Voice Handicap Index‐10 (VHI‐10) score, acoustic parameters, maximum phonation time (MPT), and disease regression. The mean follow‐up period was 12.79 ± 12.31 weeks.

Results

A total of 29 patients with vocal fold polyps were included in the study. Twenty‐one patients had hemorrhagic polyps, while the remaining had nonhemorrhagic polyps. No significant differences in the demographic variables were noted between the two subgroups. The mean VHI‐10 score in the hemorrhagic polyp subgroup decreased by 10.2 ± 6.76 points, compared to 6.33 ± 7.14 points in the nonhemorrhagic subgroup ( p = 0.208). There was a significant difference in complete disease regression between the hemorrhagic and nonhemorrhagic subgroups (95.2% vs. 62.5% p = 0.022). No significant differences were observed in any of the acoustic parameters between the two subgroups except for jitter ( p = 0.017).

Conclusion

The results of this investigation indicate that hemorrhagic vocal fold polyps respond better to office‐based blue laser therapy with intralesional steroid injection than nonhemorrhagic polyps. Level of Evidence 3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolypsVocal CordsLaryngeal DiseasesHemorrhageLaser TherapyHumansFemaleMaleMiddle AgedInjections, IntralesionalTreatment OutcomeRetrospective StudiesAdultAged

Stichwörter der Autor:innen

blue laserdisease regressionoffice‐basedvocal fold polypvoice outcome

Autor:innen und Institutionen

  • Department of Otolaryngology - Head and Neck Surgery, American University of Beirut Medical Center, Beirut, Lebanon.

ORCID-Profile: Abdul-Latif Hamdan, Jad Hosri

Zitieren

APA

Hamdan, A. L., Abou Raji Feghali, P., Ghzayel, L., Lababidi, G., Sarkis, V., Hosri, J., Alam, E., & Mourad, M. (2026). Office‐Based Blue Laser Therapy and Steroid Injection of Hemorrhagic and Nonhemorrhagic Vocal Fold Polyp. The Laryngoscope. https://doi.org/10.1002/lary.70671

Vancouver

Hamdan AL, Abou Raji Feghali P, Ghzayel L, Lababidi G, Sarkis V, Hosri J, et al. Office‐Based Blue Laser Therapy and Steroid Injection of Hemorrhagic and Nonhemorrhagic Vocal Fold Polyp. The Laryngoscope. 2026. doi:10.1002/lary.70671

BibTeX
@article{Hamdan2026,
  author = {Hamdan, Abdul-Latif and Abou Raji Feghali, Patrick and Ghzayel, Lana and Lababidi, Ghena and Sarkis, Valerie and Hosri, Jad and Alam, Elie and Mourad, Marc},
  title = {Office‐Based Blue Laser Therapy and Steroid Injection of Hemorrhagic and Nonhemorrhagic Vocal Fold Polyp},
  journal = {The Laryngoscope},
  year = {2026},
  doi = {10.1002/lary.70671}
}
Kostenlos starten →